Browse > Article
http://dx.doi.org/10.5012/bkcs.2014.35.8.2290

Recombinant Human Epidermal Growth Factor (rhEGF)-loaded Solid Lipid Nanoparticles: Fabrication and Their Skin Accumulation Properties for Topical rhEGF Delivery  

Hwang, Hee-Jin (Department of Smart Foods and Drugs, Inje University)
Han, Sunhui (Department of Smart Foods and Drugs, Inje University)
Jeon, Sangok (Department of Smart Foods and Drugs, Inje University)
Seo, Joeun (College of Pharmacy, Keimyung University)
Oh, Dongho (Department of Smart Foods and Drugs, Inje University)
Cho, Seong-Wan (Department of Pharmaceutical Engineering, Konyang University)
Choi, Young Wook (Division of Pharmaceutical Sciences, College of Pharmacy, Chung-Ang University)
Lee, Sangkil (College of Pharmacy, Keimyung University)
Publication Information
Abstract
For the present study, rhEGF was encapsulated into solid lipid nanoparticles (SLNs). The SLNs were prepared by the $W_1/O/W_2$ double emulsification method combined with the high pressure homogenization method and the physical properties such as particle size, zeta-potential and encapsulation efficiency were measured. The overall particle morphology of SLNs was investigated using a transmission electron microscopy (TEM). The percutaneous skin permeation and accumulation property of rhEGF was evaluated using Franz diffusion cell system along with confocal laser scanning microscopy (CLSM). The mean particle size of rhEGF-loaded SLNs was $104.00{\pm}3.99nm$ and the zeta-potential value was in the range of -$36.99{\pm}0.54mV$, providing a good colloidal stability. The TEM image revealed a spherical shape of SLNs about 100 nm and the encapsulation efficiency was $18.47{\pm}0.22%$. The skin accumulation of rhEGF was enhanced by SLNs. CLSM image analysis provided that the rhEGF rat skin accumulation is facilitated by an entry of SLNs through the pores of skin.
Keywords
Solid lipid nanoparticle (SLN); Recombinant human epidermal growth factor (rhEGF); $W_1/O/W_2$ double emulsification; Skin accumulation; Topical drug delivery;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Carpenter, G.; Cohen, S. Annu. Rev. Biochem. 1979, 48, 193.   DOI   ScienceOn
2 Verma, D. D.; Verma, S.; Blume, G.; Fahr, A. Eur. J. Pharm. Biopharm. 2003, 55, 271.   DOI   ScienceOn
3 Du Plessis, J. L.; Boersema, B. R.; Van Strijp, M. F. Onderstepoort J. Vet. Res. 1994, 61, 277.
4 Todo, H.; Kimura, E.; Yasuno, H.; Tokudome, Y.; Hashimoto, F.; Ikarashi, Y.; Sugibayashi, K. Biol. Pharm. Bull. 2010, 33, 1394.   DOI   ScienceOn
5 Chen, H.; Chang, X.; Du, D.; Liu, W.; Liu, J.; Weng, T.; Yang, Y.; Xu, H.; Yang, X. J. Control. Release 2006, 110, 296.   DOI   ScienceOn
6 Pedersen, N.; Hansen, S.; Heydenreich, A. V.; Kristensen, H. G.; Poulsen, H. S. Eur. J. Pharm. Biopharm. 2006, 62, 155.   DOI   ScienceOn
7 Li, L.; Lishko, V.; Hoffman, R. M. In Vitro Cell Dev Biol. Anim. 1993, 29A, 258.
8 Müller, R. H.; Peters, K. Int. J. Pharm. 1998, 160, 229.   DOI   ScienceOn
9 Wissing, S. A.; Müller, R. H. Eur. J. Pharm. Biopharm. 2003, 56, 67.   DOI   ScienceOn
10 Tripathi, G.; Dubey, B. J. Global Pharm. Technol. 2011, 3, 14.
11 Choi, M. J.; Maibach, H. I. Skin Pharmacol. Physiol. 2005, 18, 209.   DOI   ScienceOn
12 Lee, S. G.; Jeong, J. H.; Kim, S. R.; Lee, K. M.; Ahn, B. K.; Kang, M. H.; Choi, Y. W. J. Pharm. Invest. 2012, 42, 243.   DOI
13 Benson, H. A.; Namjoshi, S. J. Pharm. Sci. 2008, 97, 3591.   DOI   ScienceOn
14 Verma, D. D.; Fahr, A. J. Control. Release 2004, 97, 55.   DOI   ScienceOn
15 Lopez-Pinto, J. M.; Gonzalez-Rodriguez, M. L.; Rabasco, A. M. Int. J. Pharm. 2005, 298, 1.   DOI   ScienceOn
16 Mittal, A.; Sara, U.; Ali, A.; Aqil, M. Biol. Pharm. Bull. 2008, 31, 1766.   DOI   ScienceOn
17 Tokudome, Y.; Sugibayashi, K. J. Control. Release 2003, 92, 93.   DOI   ScienceOn
18 Katikaneni, S.; Li, G.; Badkar, A.; Banga, A. K. J. Drug Target. 2010, 18, 141.   DOI   ScienceOn
19 Paturi, J.; Kim, H. D.; Chakraborty, B.; Friden, P. M.; Banga, A. K. J. Drug Target. 2010, 18, 134.   DOI   ScienceOn
20 Barichello, J. M.; Handa, H.; Kisyuku, M.; Shibata, T.; Ishida, T.; Kiwada, H. J. Control. Release 2006, 115, 94.   DOI   ScienceOn
21 Rawat, M.; Singh, D.; Saraf, S.; Saraf, S. Biol. Pharm. Bull. 2006, 29, 1790.   DOI   ScienceOn
22 Yoon, G.; Park, J. W.; Yoon, I.-S. J. Pharm. Invest. 2013, 43, 353.   DOI   ScienceOn
23 Wissing, S. A.; Muller, R. H. Int. J. Pharm. 2003, 254, 65.   DOI   ScienceOn
24 Iwasaki, S.; Aoyagi, H.; Yoshizawa, H. Acta Histochem. 2007, 109, 37.   DOI   ScienceOn
25 Cohen, S.; Carpenter, G. Proc. Natl. Acad. Sci. USA 1975, 72, 1317.   DOI   ScienceOn
26 Gregory, H. Nature 1975, 257, 325.   DOI   ScienceOn
27 Taylor, J. M.; Mitchell, W. M.; Cohen, S. J. Biol. Chem. 1972, 247, 5928.
28 Carpenter, G.; Cohen, S. J. Biol. Chem. 1990, 265, 7709.
29 Senderoff, R. I.; Wootton, S. C.; Boctor, A. M.; Chen, T. M.; Giordani, A. B.; Julian, T. N.; Radebaugh, G. W. Pharm. Res. 1994, 11, 1712.   DOI   ScienceOn
30 Alemdaroglu, C.; Degim, Z.; Celebi, N.; Zor, F.; Ozturk, S.; Erdogan, D. Burns 2006, 32, 319.   DOI   ScienceOn
31 Hong, J. P.; Jung, H. D.; Kim, Y. W. Ann. Plast. Surg. 2006, 56, 394.   DOI   ScienceOn
32 Tong, W. Y.; Yao, S. J.; Zhu, Z. Q. Chemical Engineering Science 2001, 56, 6959.   DOI   ScienceOn
33 Chen, X.; Cen, P.; Chen, J. J. Biosci. Bioeng. 2005, 100, 579.   DOI   ScienceOn
34 Choi, C. M.; Berson, D. S. Semin. Cutan. Med. Surg. 2006, 25, 163.   DOI   ScienceOn
35 Ulubayram, K.; Nur Cakar, A.; Korkusuz, P.; Ertan, C.; Hasirci, N. Biomaterials 2001, 22, 1345.   DOI   ScienceOn
36 Lauer, A. C.; Lieb, L. M.; Ramachandran, C.; Flynn, G. L.; Weiner, N. D. Pharm. Res. 1995, 12, 179.   DOI
37 Bouwstra, J. A.; Honeywell-Nguyen, P. L.; Gooris, G. S.; Ponec, M. Prog. Lipid. Res. 2003, 42, 1.   DOI   ScienceOn
38 Elsayed, M. M.; Abdallah, O. Y.; Naggar, V. F.; Khalafallah, N. M. Int. J. Pharm. 2007, 332, 1.   DOI   ScienceOn